Why Companies Swallow Poison Pills
In February of 2019, the international business community was abuzz after biopharmaceutical company Sinovacmade a rare and bold power play.In response to a perceived threat to its board of directors, the companyactivated a shareholder rights planto reissue more than twenty-five million new shares to certain shareholders, which would give them greater control of the company, but simultaneously reduce their value substantially...
Read Full Article
